Is a PEG PAL research study right for you?
People with phenylketonuria (PKU) can't process one of the amino acids found in many foods. The amino acid, called phenylalanine or "Phe" for short, builds up in the body. There are approximately 16,000 adults living with PKU in the United States and Canada.
Clinical research helps us learn more about treatment options for PKU.
The Prism 301 clinical research study is testing an experimental enzyme substitution therapy called rAvPAL-PEG (also known as PEG PAL) as a potential new type of treatment for adults with PKU. This study is for people 18 to 70 years of age.